Gsk Plc (GSK.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Cash Flows From Operating Activities | |||||
| Other Working Capital | 1,677,000 | -889,000 | 2,144,000 | -155,000 | 229,000 |
| Other Operating Activity | -212,000 | 1,983,000 | -28,000 | 2,277,000 | 2,032,000 |
| Operating Cash Flow | $1,465,000 | $1,094,000 | $2,116,000 | $2,122,000 | $2,261,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -254,000 | -240,000 | -238,000 | -190,000 | -424,000 |
| Net Acquisitions | -187,000 | -4,000 | -163,000 | 0 | -115,000 |
| Purchase Of Investment | -119,000 | -31,000 | -116,000 | -74,000 | -39,000 |
| Sale Of Investment | 36,000 | 14,000 | 30,000 | 38,000 | -141,000 |
| Purchase Sale Intangibles | -89,000 | -240,000 | -47,000 | -119,000 | -185,000 |
| Other Investing Activity | 127,000 | 49,000 | 54,000 | 21,000 | 203,000 |
| Investing Cash Flow | $-554,000 | $-478,000 | $-512,000 | $-324,000 | $-711,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,000 | -9,000 | -673,000 | -610,000 | -250,000 |
| Debt Repayment | -10,000 | -11,000 | -13,000 | -11,000 | -15,000 |
| Common Stock Issued | 35,000 | 17,000 | 4,000 | 23,000 | 33,000 |
| Common Stock Repurchased | 50,000 | -8,000 | -2,000 | -56,000 | -1,000 |
| Dividend Paid | -759,000 | -764,000 | -919,000 | -763,000 | -717,000 |
| Other Financing Activity | -338,000 | -104,000 | -452,000 | -200,000 | -347,000 |
| Financing Cash Flow | $-1,020,000 | $-879,000 | $-2,055,000 | $-1,617,000 | $-1,297,000 |
| Exchange Rate Effect | 30,000 | -29,000 | -23,000 | 103,000 | -6,000 |
| Beginning Cash Position | 5,886,000 | 6,178,000 | 6,652,000 | 6,368,000 | 6,121,000 |
| End Cash Position | 5,807,000 | 5,886,000 | 6,178,000 | 6,652,000 | 6,368,000 |
| Net Cash Flow | $-109,000 | $-263,000 | $-451,000 | $181,000 | $253,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 1,465,000 | 1,094,000 | 2,116,000 | 2,122,000 | 2,261,000 |
| Capital Expenditure | -446,000 | -517,000 | -346,000 | -326,000 | -641,000 |
| Free Cash Flow | 1,019,000 | 577,000 | 1,770,000 | 1,796,000 | 1,620,000 |